Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction
Top Cited Papers
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 37 (7), 1781-1787
- https://doi.org/10.1016/s0735-1097(01)01269-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- The Amino-Terminal Portion of Pro-Brain Natriuretic Peptide (Pro-BNP) Circulates in Human PlasmaBiochemical and Biophysical Research Communications, 1995
- Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cellsFEBS Letters, 1995
- AdrenomedullinDrugs, 1995
- Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captoprilJournal of the American College of Cardiology, 1994
- Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasmaFEBS Letters, 1994
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984